(Q38936732)

7 September 2017

title

LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression (English)

1 reference

7 September 2017

1 reference

S Bianco

1

1 reference

7 September 2017

M Jangal

series ordinal

2

1 reference

7 September 2017

D Garneau

series ordinal

3

1 reference

7 September 2017

N Gévry

series ordinal

4

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

7 September 2017

1 reference

7 September 2017

volume

34

1 reference

7 September 2017

issue

34

1 reference

7 September 2017

page(s)

4509-4518

1 reference

Breast cancer classification by proteomic technologies: current state of knowledge

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Endocrine resistance in breast cancer: from cellular signaling pathways to epigenetic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Nuclear receptor LRH-1 induces the reproductive neuropeptide kisspeptin in the hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Liver receptor homolog 1 is essential for ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Liver receptor homolog-1 is essential for pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Colon cancer cells produce immunoregulatory glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Therapeutic potential of Liver Receptor Homolog-1 modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

LRH-1-dependent glucose sensing determines intermediary metabolism in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Immunolocalization of liver receptor homologue-1 (LRH-1) in human breast carcinoma: possible regulator of insitu steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

LRH-1 governs vital transcriptional programs in endocrine-sensitive and -resistant breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Distinct nuclear receptor expression in stroma adjacent to breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Oestradiol reduces liver receptor homolog-1 mRNA transcript stability in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

A large fraction of extragenic RNA pol II transcription sites overlap enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

FOXA1 is a key determinant of estrogen receptor function and endocrine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Histone H3K27ac separates active from poised enhancers and predicts developmental state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Histone modifications at human enhancers reflect global cell-type-specific gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Mechanisms of Endocrine Resistance in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Examination of the expanding pathways for the regulation of p21 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

21 January 2018

p53 mutations in cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Up-regulation of p21 gene expression by peroxisome proliferator-activated receptor gamma in human lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The transcriptional co-repressor TLE3 suppresses basal signaling on a subset of estrogen receptor α target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

F-Seq: a feature density estimator for high-throughput sequence tags

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

FoxA1 is a key mediator of hormonal response in breast and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.382

Estrogen regulated expression of the p21 Waf1/Cip1 gene in estrogen receptor positive human breast cancer cells

31 March 2020

1 reference

12 December 2020

MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen

1 reference

12 December 2020

Androgen induction of cyclin-dependent kinase inhibitor p21 gene: role of androgen receptor and transcription factor Sp1 complex

1 reference

12 December 2020

Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.

1 reference

12 December 2020

Identifiers

DOI

10.1038/ONC.2014.382

1 reference

Dimensions Publication ID

7 September 2017

1016634353

0 references

1 reference